Synthesis and anaerobic biodegradation of indomethacin-conjugated cellulose ethers used for colon-specific drug delivery

被引:34
作者
Cai, Xiang [1 ]
Yang, Liqun [1 ,2 ,3 ,4 ,5 ]
Zhang, Li-Ming [1 ,4 ,5 ]
Wu, Qing [1 ,4 ,5 ]
机构
[1] Sun Yat Sen Univ, Inst Polymer Sci, Sch Chem & Chem Engn, Guangzhou 510275, Guangdong, Peoples R China
[2] Chinese Acad Sci, Key Lab Cellulose & Lignocellulos Chem, Guangzhou Inst Chem, Guangzhou 510650, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, BME Ctr, State Key Lab Optoelect Mat & Technol, Guangzhou 510275, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, DSAPM Lab, Sch Chem & Chem Engn, Guangzhou 510275, Guangdong, Peoples R China
[5] Sun Yat Sen Univ, PCFM Lab, OFCM Inst, Guangzhou 510275, Guangdong, Peoples R China
关键词
Hydroxyethylcellulose; Indomethacin; Methylcellulose; Molecular weight; Short chain fatty acid; IN-VITRO; BACTERIA; FERMENTATION; PEPTIDE; DEGRADATION; INOCULUM; PROTEIN; TARGET; GROWTH;
D O I
10.1016/j.biortech.2009.04.005
中图分类号
S2 [农业工程];
学科分类号
0828 ;
摘要
Water soluble cellulose ethers, including methylcellulose and two hydroxyethylcelluloses with different molecular weights, were conjugate with indomethacin at room temperature. The chemical structures of the conjugates were characterized by FTIR. H-1 NMR and UV-vis spectroscopy. The results confirmed that different amounts of IND residues were covalently bonded to cellulose ether backbones through ester linkages. Their anaerobic biodegradation in colonic fermentation was investigated by gel permeation chromatography, gas chromatography and UV-vis spectroscopy. These conjugates were found to have different biodegradabilities, depending on the cellulose ether used and the amount of conjugated indomethacin residues. In vitro release experiments showed that hydroxyethylcellulose-based conjugates with low IND residues content could exhibit a sustained drug release behavior in colonic fermentation and were stable in the simulated media of the stomach and small intestine. Therefore, they are promising candidates for future applications in colon-specific drug delivery. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4164 / 4170
页数:7
相关论文
共 30 条
[11]   Oral delivery of peptide drugs -: Barriers and developments [J].
Hamman, JH ;
Enslin, GM ;
Kotzé, AF .
BIODRUGS, 2005, 19 (03) :165-177
[12]  
Haupt S, 2002, CRIT REV THER DRUG, V19, P499
[13]  
Insel P.A., 1996, PHARMACOL BASIS THER, P633
[14]  
Lönnroth C, 2001, INT J ONCOL, V18, P929
[15]   EFFECT OF INDOMETHACIN ON THE GROWTH OF COLON CANCER-CELLS IN SYNGENEIC RATS [J].
OLSSON, NO ;
CAIGNARD, A ;
MARTIN, MS ;
MARTIN, F .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1984, 6 (04) :329-334
[16]   Therapeutic opportunities in colon-specific drug-delivery systems [J].
Patel, Mayur ;
Shah, Tejal ;
Amin, Avani .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2007, 24 (02) :147-202
[17]  
POLLARD M, 1980, CANCER TREAT REP, V64, P1323
[18]   The cellulolytic microflora of the human colon: evidence of microcrystalline cellulose-degrading bacteria in methane-excreting subjects [J].
Robert, C ;
Bernalier-Donadille, A .
FEMS MICROBIOLOGY ECOLOGY, 2003, 46 (01) :81-89
[19]   Interspecies H2 transfer in cellulose degradation between fibrolytic bacteria and H2-utilizing microorganisms from the human colon [J].
Robert, C ;
Del'Homme, C ;
Bernalier-Donadille, A .
FEMS MICROBIOLOGY LETTERS, 2001, 205 (02) :209-214
[20]  
Rodriguez C.F., 2000, Handbook of Pharmaceutical Controlled Release Technology, P1